Shares of Proteome Sciences plc (LON:PRM – Get Free Report) were up 22.8% on Friday . The stock traded as high as GBX 4.20 ($0.05) and last traded at GBX 4.20 ($0.05). Approximately 338,224 shares were traded during trading, an increase of 83% from the average daily volume of 185,236 shares. The stock had previously closed at GBX 3.42 ($0.04).
Proteome Sciences Trading Up 22.8 %
The company has a market cap of £12.40 million, a P/E ratio of -420.00 and a beta of 0.07. The company’s 50-day moving average price is GBX 2.92 and its two-hundred day moving average price is GBX 3.11.
Proteome Sciences Company Profile
Proteome Sciences plc provides contract research services for the identification, validation, and application of protein biomarkers in the United States, the United Kingdom, European Union, and internationally. The company offers TMT LC-MS2, a standard method for analyzing cells and tissues when no phosphopeptide enrichment is required; TMT LC-MS3, a standard method for biomarker discovery in plasma and other samples where quantitative accuracy is a factor; SysQuant, provides an analysis of protein activity across regulatory and signaling pathways; and TMTcalibrator, analyzes where diseased or treated tissue can be analyzed in parallel with peripheral fluids.
Read More
- Five stocks we like better than Proteome Sciences
- Stock Market Holidays 2022-2025 – Here’s When the NYSE and NASDAQ Will be Closed
- 3 EV Stocks Offering Unique Alternatives to Tesla
- Earnings Per Share Calculator: How to Calculate EPS
- 3 Stocks Leveraging NVIDIA’s Strength for Profits
- The Top 3 Healthcare Dividend Stocks to Buy and Hold
- Walgreens Stock Poised for a Rebound: Why Analysts Are Bullish
Receive News & Ratings for Proteome Sciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Proteome Sciences and related companies with MarketBeat.com's FREE daily email newsletter.
